deltatrials

Stage iiia breast cancer Trials in Rochester, United States

Conditions / Stage iiia breast cancer / Rochester, United States

Research into Stage iiia breast cancer spans multiple therapeutic approaches and trial phases.

16 total trials for this combination

Showing top 10 of 16 trials

Trials

NCT ID Title Status Phase
NCT03414970 Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer ACTIVE_NOT_RECRUITING PHASE3
NCT03971409 Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer ACTIVE_NOT_RECRUITING
NCT00066690 Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer COMPLETED PHASE3
NCT03188393 Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery COMPLETED PHASE2
NCT01953588 Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery ACTIVE_NOT_RECRUITING PHASE3
NCT02445391 Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy ACTIVE_NOT_RECRUITING PHASE3
NCT00513292 Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery COMPLETED PHASE3
NCT02488967 Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer ACTIVE_NOT_RECRUITING PHASE3
NCT02646319 Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations COMPLETED EARLY_PHASE1
NCT01901094 Comparison of Axillary Lymph Node Dissection with Axillary Radiation for Patients with Node-Positive Breast Cancer Treated with Chemotherapy ACTIVE_NOT_RECRUITING PHASE3

Related Pages